APEX2 and triple-negative breast carcinoma: The LOX-APEX2 variants were stably expressed in human triple negative breast cancer MDA-MB-231 cells and we confirmed that they were secreted as expected, and that LOXΔBMP1-APEX2 was not cleaved to the mature active form (Supplementary Fig. 1a,b).